Ran Achituv

Quantum & Deep-tech investor, Entree Capital & Chairman of Advisory Board and Alumni at Efi Arazi School of Computer Science

📍 Israel, Israel🔄 Updated September 2026💼 29 investments📅 16 years investing🗓 Last invested Apr 2026𝕏 @upgrade_to_unlock
VC🌍 Israel20+ investmentsInvested this year
29
Total investments
15
Early stage
4
Mid stage
4
Late stage
16y
Years active

Portfolio

27 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Apr 2026
Resolight is removing the complexity in AI infrastructure and using photonic processing to make the network 10X more scalable, faster and efficient. Resolight photonic processing technology boosts bandwidth, lowers energy, and disrupts the economics of AI infrastructure by an order of magnitude by eliminating the bottleneck around electronic processing which is critical for AI datacenter scaling and profitability. Resolight is actively working with design partners to develop all-optical switching systems. These networking systems will also work with optical technologies in development, such as CPO and LPO making the networks 10X more scalable.
Investor
Jun 2024
Cavos Biotech is an emerging genomic and data science company focusing on the development of novel drugs based on naturally occurring resistance mechanisms for various diseases. We are developing a multi-level genomic algorithm to uncover the genetic base of extraordinary cancer resistance found in specific, and across various animals. We harness the genomic and data revolution and use high resolution identification methods to uncover existing anti-cancer mechanisms, and novel drug targets, and to revolutionize the way by which drug targets are discovered and identified.
mid stageBiotechnology
Board Member
May 2023
Diamond Electronics develops revolutionary diamond semiconductors for the next generation electronics of high-power and high-frequency devices.
Investor and Board Observer
Jan 2023
At NVision, we engineer quantum-powered medical imaging technologies that deliver deeper, more precise MRI data for researchers and clinicians. Our unique hyperpolarization device POLARIS enables fast, simple, scalable imaging of metabolism at the cellular level. With hyperpolarized MRI, we are paving the way for earlier detection, faster treatment assessment and better risk profiling in oncology, cardiology, neurology and beyond.
Board Observer
Nov 2022
Full Stack Quantum Computing
Board Member
May 2022
Sweetch is the first behavioral science company to leverage AI & EI (emotional intelligence) through its digital therapeutics solutions. Its hyper-personalized engagement platform enables health ecosystem players to build continuous relationships and engage with every individual patient, at scale.
Board Member
Jun 2021
Livez is pioneering the new era of preventive care – “Autonomous Prevention”. A comprehensive solution for Personalized, Predictive, Proactive, Prevention (P4 Medicine), fully-automated on mobile phones. Livez transforms the mobile phone into a screening device, making clinical prevention accessible and easy! Members use their mobile phone to perform “on time” screenings, across 50+ clinical domains, leveraging clinically validated AI technologies. Our comprehensive solution combines this experience with real time booking for screenings and vaccines with in-network providers, and connecting members with ecosystem solutions, based on their individual risks, preventing diseases before symptoms occur. The goal is systematic clinical prevention and early detection of 85% of diseases, across a diverse and distributed population, bending the cost curve by impacting 75% of claims!
Board Member
Jun 2021
At LiteBC we believe in harnessing cutting edge technology to the benefit of the populations health. Our first product, the HemoScope will enable immediate, non-invasive blood analysis at the point of care.
Investor
Apr 2021
Omnix Medical is a clinical company, dedicated to the development and commercialization of highly effective antibiotic agents against resistant pathogenic bacterial strains, a highly common problem in todays medicine especially in chronic conditions and in modern hospitals. These agents are based on natural antimicrobial peptides, genetically engineered to be compatible for therapeutic use. Omnix is addressing an enormous and rapidly growing market opportunity, represented by millions of Americans and many more millions worldwide, who suffer from infections associated with resistant bacteria.
Investor
Dec 2020
An Israeli-UK company founded by world-class scientists.
early stageResearch
Board Member
Oct 2020
Vortex Imaging is developing a novel medical imaging device (hardware and software) that has the potential to revolutionize the imaging world, saving thousands of lives annually and addressing a $120B+ market, by delivering high-quality imaging, at low cost, anywhere and at the hand of anyone. We are developing the worlds first handheld, full volumetric (3D), operator independent, low-cost and safe imaging modality, based on geophysics inspired algorithms and computational software running with GPUs on Cloud.
Board Member
Jul 2020
At Bria, we provide a comprehensive solution for Visual Generative AI built in the right way for commercial use. Our solutions tackle the essential challenges organizations encounter when deploying Visual Generative AI for commercial purposes across every department: Business, Product, and Technology. Whether youre a research team seeking flexibility, a product team in search of holistic strategies, or a commercial team needing trusted solutions, BRIA delivers a complete array of commercial, ready-to-use Generative AI solutions. From AI Foundation Models to Service Tools, APIs, iFrame / SDK, and beyond, our offering covers it all. Trained exclusively on licensed and safe-to-use data, we ensure theres no copyright infringement or harmful content. This empowers creators, businesses and developers to build with confidence, fostering an unwavering trust for both you and your clients. With a steadfast commitment to quality and responsible AI, our pre-configured features and tools are designed to meet your specific needs, right away. By empowering organizations with the capability to build amazing products using Visual Generative AI solutions with ultimate flexibility, we enable them to harness this technology to its full commercial potential. Explore how BRIA can cater to your specific Visual Generative AI commercial use case, free from any legal or safety risks. Connect with us today!
Board Member
Jun 2020
Welcome to Classiq - Leading Quantum Computing Software Inspired by traditional semiconductor design automation, Classiq combines deep quantum expertise with novel implementation of classical computing software automation. This combination of deep technologies is designed to transform the quantum software stack, today and in the future. With an IDE, SDK, Compiler and OS for quantum computing, Classiq is positioned at the intersection of quantum physics and computer science. Classiq’s transformative offering is being woven into the fabric of the quantum computing ecosystem: QUANTUM DEVELOPERS: As quantum computers get more powerful gate-level manual coding becomes impractical, and at times impossible. Classiq’s unique technology changes that. Classiq’s high-level quantum development environment offers functional libraries and deploys advanced heuristics and algorithms to synthesize quantum circuits automatically. Experts and beginners alike are now able to implement advanced scalable quantum circuits that are automatically optimized for a specific quantum machine, as well as easy benchmarking. Execution on quantum machines and simulators is built-in. QUANTUM COMPUTER PROVIDERS: Classiq’s software can be deployed as a dedicated front-end operating system offering customers best-in-class features maximizing customer insights and productivity. QUANTUM CLOUDS: Classiq’s hardware agnostic development software enables programs in all leading quantum programming languages providing broad access to and driving adoption of cloud platforms. HPC & ADVANCED COMPUTATION: Classiq’s scalable automation and classical computing underpinning make it a natural partner for today’s supercomputing providers seeking to integrate seamlessly with quantum computing. Classiq is collaborating with the world’s leading supercomputing providers to build seamless architectures to combine the best of both classical and quantum computing.
Show all 27 investments ↓
Experience · 34 entries
All (34)
Investments (29)
Founder (2)
Board (24)
2026
Board Member
Apr 2026
Resolight is removing the complexity in AI infrastructure and using photonic processing to make the network 10X more scalable, faster and efficient. Resolight photonic processing technology boosts bandwidth, lowers energy, and disrupts the economics of AI infrastructure by an order of magnitude by eliminating the bottleneck around electronic processing which is critical for AI datacenter scaling and profitability. Resolight is actively working with design partners to develop all-optical switching systems. These networking systems will also work with optical technologies in development, such as CPO and LPO making the networks 10X more scalable.
2024
Investor
Jun 2024
Cavos Biotech is an emerging genomic and data science company focusing on the development of novel drugs based on naturally occurring resistance mechanisms for various diseases. We are developing a multi-level genomic algorithm to uncover the genetic base of extraordinary cancer resistance found in specific, and across various animals. We harness the genomic and data revolution and use high resolution identification methods to uncover existing anti-cancer mechanisms, and novel drug targets, and to revolutionize the way by which drug targets are discovered and identified.
mid stageBiotechnology
2023
Board Member
May 2023
Diamond Electronics develops revolutionary diamond semiconductors for the next generation electronics of high-power and high-frequency devices.
Investor and Board Observer
Jan 2023
At NVision, we engineer quantum-powered medical imaging technologies that deliver deeper, more precise MRI data for researchers and clinicians. Our unique hyperpolarization device POLARIS enables fast, simple, scalable imaging of metabolism at the cellular level. With hyperpolarized MRI, we are paving the way for earlier detection, faster treatment assessment and better risk profiling in oncology, cardiology, neurology and beyond.
Show all 34 entries ↓
Investment activity
2010–2026 · 29 investments
20101201422015220162201712018220193202052021320223202322024220261
Recent (last 2 years)Earlier